Priti Bhardwaj, MD
Psychiatry · Santa Ana
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 26 years
- Indiana University School of Medicine, 2000
Offices
2 locations · Pacific Neuropsychiatric Specialists Inc · Eagan Medical Group Inc
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bhardwaj’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A94479 · Current
Licensed to practise in California · since 2006 · expires 2028-02-29 · Indiana University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Child and Adolescent Psychiatry
- American Board of Psychiatry and Neurology - Psychiatry
Original Medicare doctor bills
$3,477
Medicare paid this office $3,477 for 13 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
13 Original Medicare patients in 2024. Average age 62 · 85 and older 0% · Health risk score 1.75. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
The office billed $17,440, Medicare allowed $4,925 and paid $3,477; for 39 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 13 | 39 | 62 | 1.75 | $17,440 | $3,477 |
| 2023 | 24 | 87 | 64 | 1.72 | $22,277 | $7,753 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $1,805 | $58 |
| Short return visit (20+ min) | 12 | $1,042 | $65 |
Medicaid work
$480,671 in 2024
Medicaid paid $480,671 for 5,166 billed services this clinician did in 2024, up to 368 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 1,781 | $166,609 |
| Return visit (30+ min) | 1,132 | $119,341 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 1,523 | $90,395 |
| New patient visit (60+ min) | 344 | $59,685 |
| Long return visit (40+ min) | 273 | $42,495 |
| Developmental screening | 16 | $1,054 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; capable of being read by direct optical observation only (eg, utilizing immunoassay [eg, dipsticks, cups, cards, or cartridges]), includes sample validation when performed, per date of service | 84 | $848 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 13 | $244 |
| 2024 | 5,166 | 8 | 368 | $480,671 |
| 2023 | 1,393 | 4 | 231 | $102,771 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 523 | $36,768 |
| Short return visit (20+ min) | 561 | $36,269 |
| New patient visit (60+ min) | 154 | $23,240 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 155 | $6,494 |
Drugs they prescribed that Part D paid
$3,023
Pharmacies billed $3,023 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 71) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
71 generic and 0 brand-name prescriptions · $3,023 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lamotrigine | 11 | $20 | $2 |
Year by year
| 2024 | 71 | None | 0% (0) | 0% | $3,023 |
| 2023 | 119 | 16 | 0% (0) | None | $7,979 |
| 2022 | 176 | 17 | None | None | $6,634 |
| 2021 | 261 | 26 | None | 8% | $6,611 |
| 2020 | 272 | 32 | None | 15% | $47,077 |
| 2019 | 181 | 25 | None | None | $6,835 |
| 2018 | 255 | 29 | None | None | $16,289 |
| 2017 | 701 | 62 | 2% (17) | 3% | $36,263 |
| 2016 | 954 | 89 | 6% (52) | 8% | $65,136 |
| 2015 | 1,280 | 107 | 11% (139) | None | $66,961 |
| 2014 | 1,110 | 103 | 14% (152) | None | $55,960 |
| 2013 | 985 | 57 | 11% (104) | None | $36,616 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Quetiapine | 17 | $992 | $58 |
| Trazodone | 14 | $274 | $20 |
| Sertraline | 11 | $176 | $16 |
2022: 8 drugs
| Quetiapine | 32 | $737 | $23 |
| Dextroamphetamine-Amphetamine | 13 | $597 | $46 |
| Divalproex Sodium Er | 13 | $470 | $36 |
| Fluoxetine | 11 | $281 | $26 |
| Trazodone | 13 | $152 | $12 |
| Mirtazapine | 15 | $147 | $10 |
| Lamotrigine | 17 | $146 | $9 |
| Hydroxyzine | 13 | $44 | $3 |
2021: 6 drugs
| Quetiapine | 26 | $909 | $35 |
| Mirtazapine | 23 | $367 | $16 |
| Lamotrigine | 18 | $143 | $8 |
| Venlafaxine Hcl Er | 19 | $129 | $7 |
| Clonazepam | 13 | $98 | $8 |
| Bupropion Hcl Sr | 11 | $63 | $6 |
2020: 7 drugs
| Latuda | 18 | $34,851 | $1,936 |
| Quetiapine | 18 | $367 | $20 |
| Lamotrigine | 23 | $214 | $9 |
| Mirtazapine | 11 | $182 | $17 |
| Clonazepam | 15 | $153 | $10 |
| Fluoxetine | 15 | $87 | $6 |
| Venlafaxine Hcl Er | 17 | $73 | $4 |
2019: 5 drugs
| Trazodone | 20 | $390 | $19 |
| Mirtazapine | 14 | $145 | $10 |
| Quetiapine | 11 | $112 | $10 |
| Venlafaxine Hcl Er | 17 | $90 | $5 |
| Lorazepam | 11 | $61 | $6 |
2018: 11 drugs
| Trazodone | 31 | $804 | $26 |
| Gabapentin | 14 | $225 | $16 |
| Fluoxetine | 11 | $150 | $14 |
| Lamotrigine | 16 | $147 | $9 |
| Bupropion Hcl Sr | 15 | $135 | $9 |
| Quetiapine | 18 | $133 | $7 |
| Mirtazapine | 11 | $105 | $10 |
| Venlafaxine Hcl Er | 14 | $100 | $7 |
| Lorazepam | 12 | $94 | $8 |
| Alprazolam | 11 | $70 | $6 |
| Clonazepam | 12 | $56 | $5 |
2017: 22 drugs
| Aripiprazole | 43 | $15,966 | $371 |
| Quetiapine | 71 | $1,208 | $17 |
| Bupropion Xl | 41 | $1,017 | $25 |
| Ziprasidone | 12 | $761 | $63 |
| Lamotrigine | 45 | $515 | $11 |
| Buspirone | 11 | $453 | $41 |
| Dextroamphetamine-Amphetamine | 13 | $399 | $31 |
| Bupropion Hcl Sr | 28 | $377 | $13 |
| Fluoxetine | 21 | $329 | $16 |
| Clonazepam | 51 | $270 | $5 |
| Alprazolam | 46 | $267 | $6 |
| Venlafaxine Hcl Er | 37 | $263 | $7 |
| Gabapentin | 12 | $256 | $21 |
| Risperidone | 12 | $229 | $19 |
| Escitalopram | 13 | $222 | $17 |
| Sertraline | 28 | $163 | $6 |
| Diazepam | 24 | $152 | $6 |
| Benztropine Mesylate | 13 | $123 | $9 |
| Lorazepam | 13 | $93 | $7 |
| Zolpidem | 19 | $89 | $5 |
| Temazepam | 16 | $86 | $5 |
| Trazodone | 12 | $60 | $5 |
2016: 25 drugs
| Aripiprazole | 36 | $19,927 | $554 |
| Bupropion Xl | 55 | $1,147 | $21 |
| Quetiapine | 54 | $1,001 | $19 |
| Dextroamphetamine-Amphetamine | 13 | $614 | $47 |
| Lamotrigine | 51 | $468 | $9 |
| Venlafaxine Hcl Er | 53 | $445 | $8 |
| Acetaminophen-Codeine | 18 | $396 | $22 |
| Clonazepam | 71 | $337 | $5 |
| Risperidone | 17 | $324 | $19 |
| Sertraline | 42 | $288 | $7 |
| Bupropion Hcl Sr | 15 | $273 | $18 |
| Fluoxetine | 21 | $237 | $11 |
| Tramadol | 17 | $195 | $11 |
| Hydrocodone-Acetaminophen | 16 | $172 | $11 |
| Haloperidol | 14 | $172 | $12 |
| Diazepam | 36 | $162 | $5 |
| Benztropine Mesylate | 15 | $158 | $11 |
| Trazodone | 19 | $149 | $8 |
| Clonidine | 12 | $111 | $9 |
| Simvastatin | 12 | $103 | $9 |
| Temazepam | 14 | $63 | $4 |
| Alprazolam | 22 | $62 | $3 |
| Lisinopril | 13 | $55 | $4 |
| Lorazepam | 11 | $52 | $5 |
| Zolpidem | 22 | $48 | $2 |
2015: 41 drugs
| Aripiprazole | 11 | $7,927 | $721 |
| Oxycodone-Acetaminophen | 26 | $2,099 | $81 |
| Hydrocodone-Acetaminophen | 48 | $1,264 | $26 |
| Quetiapine | 35 | $952 | $27 |
| Acetaminophen-Codeine | 37 | $824 | $22 |
| Bupropion Xl | 29 | $757 | $26 |
| Proair Hfa | 12 | $619 | $52 |
| Ventolin Hfa | 12 | $563 | $47 |
| Olanzapine | 12 | $497 | $41 |
| Gabapentin | 14 | $493 | $35 |
| Simvastatin | 31 | $402 | $13 |
| Haloperidol | 15 | $399 | $27 |
| Tizanidine | 15 | $289 | $19 |
| Risperidone | 23 | $286 | $12 |
| Lisinopril | 43 | $282 | $7 |
| Meclizine | 11 | $212 | $19 |
| Alprazolam | 41 | $203 | $5 |
| Fluoxetine | 26 | $202 | $8 |
| Benztropine Mesylate | 17 | $197 | $12 |
| Omeprazole | 14 | $188 | $13 |
| Levothyroxine | 21 | $169 | $8 |
| Clonazepam | 40 | $162 | $4 |
| Diazepam | 47 | $158 | $3 |
| Ranitidine | 28 | $152 | $5 |
| Metoprolol | 30 | $146 | $5 |
| Trazodone | 20 | $141 | $7 |
| Hydralazine | 11 | $140 | $13 |
| Megestrol Acetate | 11 | $132 | $12 |
| Venlafaxine Hcl Er | 17 | $126 | $7 |
| Sertraline | 24 | $116 | $5 |
| Mirtazapine | 11 | $115 | $10 |
| Lamotrigine | 21 | $113 | $5 |
| Tramadol | 21 | $108 | $5 |
| Amlodipine Besylate | 11 | $102 | $9 |
| Furosemide | 20 | $101 | $5 |
| Zolpidem | 25 | $97 | $4 |
| Metformin | 14 | $73 | $5 |
| Lorazepam | 19 | $66 | $3 |
| Ciprofloxacin | 15 | $62 | $4 |
| Lisinopril-Hydrochlorothiazide | 15 | $54 | $4 |
| Atenolol | 12 | $51 | $4 |
2014: 28 drugs
| Suboxone | 12 | $4,539 | $378 |
| Lyrica | 11 | $4,288 | $390 |
| Divalproex Sodium Er | 11 | $2,571 | $234 |
| Quetiapine | 13 | $2,461 | $189 |
| Hydrocodone-Acetaminophen | 87 | $2,203 | $25 |
| Oxycodone-Acetaminophen | 33 | $2,191 | $66 |
| Olanzapine | 11 | $1,876 | $171 |
| Simvastatin | 43 | $475 | $11 |
| Meclizine | 15 | $410 | $27 |
| Lisinopril | 48 | $356 | $7 |
| Alprazolam | 42 | $257 | $6 |
| Acetaminophen-Codeine | 15 | $198 | $13 |
| Metoprolol | 33 | $197 | $6 |
| Metformin | 20 | $173 | $9 |
| Hydralazine | 11 | $167 | $15 |
| Levothyroxine | 33 | $164 | $5 |
| Escitalopram | 15 | $154 | $10 |
| Ranitidine | 20 | $150 | $7 |
| Omeprazole | 15 | $147 | $10 |
| Trazodone | 22 | $147 | $7 |
| Sertraline | 18 | $121 | $7 |
| Warfarin | 19 | $113 | $6 |
| Azithromycin | 12 | $103 | $9 |
| Atenolol | 21 | $96 | $5 |
| Furosemide | 30 | $94 | $3 |
| Diazepam | 25 | $82 | $3 |
| Clonazepam | 13 | $78 | $6 |
| Lorazepam | 15 | $75 | $5 |
2013: 26 drugs
| Olanzapine | 14 | $5,368 | $383 |
| Quetiapine | 16 | $2,765 | $173 |
| Hydrocodone-Acetaminophen | 74 | $2,209 | $30 |
| Simvastatin | 44 | $473 | $11 |
| Oxycodone Hcl-Acetaminophen | 12 | $440 | $37 |
| Klor-Con M20 | 15 | $431 | $29 |
| Meclizine | 11 | $295 | $27 |
| Lisinopril | 38 | $293 | $8 |
| Hydralazine | 13 | $269 | $21 |
| Alprazolam | 40 | $267 | $7 |
| Metoprolol | 39 | $211 | $5 |
| Omeprazole | 19 | $176 | $9 |
| Amlodipine Besylate | 23 | $175 | $8 |
| Megestrol Acetate | 16 | $174 | $11 |
| Furosemide | 26 | $153 | $6 |
| Levothyroxine | 27 | $152 | $6 |
| Metformin | 15 | $146 | $10 |
| Trazodone | 16 | $119 | $7 |
| Meloxicam | 20 | $88 | $4 |
| Ciprofloxacin | 22 | $88 | $4 |
| Famotidine | 12 | $88 | $7 |
| Ranitidine | 12 | $88 | $7 |
| Sertraline | 11 | $87 | $8 |
| Naproxen | 21 | $84 | $4 |
| Warfarin | 16 | $76 | $5 |
| Atenolol | 16 | $74 | $5 |
Money from drug and device companies
$299 in 2025
| 2025 | 3 | 5 | None | $299 |
| 2024 | 1 | 1 | None | $29 |
| 2023 | 3 | 3 | None | $69 |
| 2022 | 2 | 3 | None | $52 |
| 2021 | 1 | 1 | None | $114 |
| 2020 | 2 | 2 | None | $43 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Invega Sustenna | $232 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $40 | 2 payments
|
| Abbvie | Vraylar | $26 | 1 payment
|
See all 5 published payments
| GlaxoSmithKline | Meals · 2025-10-06 | Trelegy Ellipta | $20 |
| Janssen Pharmaceuticals | Meals · 2025-09-09 | Invega Sustenna | $107 |
| Janssen Pharmaceuticals | Meals · 2025-05-20 | Invega Sustenna | $125 |
| GlaxoSmithKline | Meals · 2025-04-21 | Trelegy Ellipta | $20 |
| Abbvie | Meals · 2025-03-05 | Vraylar | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $29
| Abbvie | Vraylar | $29 | 1 payment
|
2023: $69
| Otsuka America Pharmaceutical | Abilify Mycite | $30 | 1 payment
|
| Corium | Adlarity | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
2022: $52
| Teva Pharmaceuticals USA | Austedo | $30 | 2 payments
|
| Corium | Adlarity | $23 | 1 payment
|
2021: $114
| Amgen | Prolia | $114 | 1 payment
|
2020: $43
| Allergan | Ubrelvy | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $22 | 1 payment
|
Professional record
- NPI
- 1750419230
- Licence
- CA A94479California A94479: Current · expires 2028-02-29
- Trained
- Indiana University School of Medicine, 2000 · 26 years ago
- Group
- Pacific Neuropsychiatric Specialists Inc · Eagan Medical Group Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 3151 Airway Ave Ste G1, Costa Mesa, CA, 92626
- NPI first listed
- 2007-02-28
- NPI last updated
- 2023-10-18
- NPI record certified
- 2023-10-03
This is when the NPI record was last certified, not a medical board exam.